1. Home
  2. Analysis
  3. Veltassa
  4. Paxil

Veltassa and Paxil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Veltassa (patiromer sorbitex calcium) and Paxil (paroxetine hydrochloride). Common drug interactions include diarrhoea among females and constipation among males.

The phase IV clinical study analyzes what interactions people have when they take Veltassa and Paxil. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Veltassa?

Veltassa has active ingredients of patiromer sorbitex calcium. eHealthMe is studying from 15,649 Veltassa users. Check the latest studies of Veltassa.

What is Paxil?

Paxil has active ingredients of paroxetine hydrochloride. It is often used in depression. eHealthMe is studying from 92,546 Paxil users. Check the latest studies of Paxil.

On Jul, 18, 2026

37 people who take Veltassa and Paxil together, and have interactions are studied.

Veltassa and Paxil drug interactions.

What are the common drug interactions of Veltassa and Paxil, by gender? *:

female:

  1. Diarrhoea
  2. Death
  3. Blood potassium increased
  4. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  5. Blood glucose decreased
  6. Cardiac failure congestive
  7. Headache (pain in head)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Nausea (feeling of having an urge to vomit)
  10. Pneumonia

male:

  1. Constipation
  2. Blood glucose increased
  3. Thyroid disorder (thyroid diseases)
  4. Blood triglycerides increased
  5. Localised infection (infection at the single location)
  6. Cardiac disorder
  7. Death
  8. Diarrhoea
  9. Epistaxis (bleed from the nose)
  10. Post procedural complication

What are the common drug interactions of Veltassa and Paxil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Blood potassium increased

30-39:

n/a

40-49:

n/a

50-59:

  1. Death

60+:

  1. Death
  2. Constipation
  3. Vomiting
  4. Gait disturbance
  5. Muscular weakness (muscle weakness)
  6. Abdominal discomfort
  7. Dizziness
  8. Epistaxis (bleed from the nose)
  9. Fall
  10. Haemorrhage (bleeding)

What are the existing conditions these people have? *

  1. Hyperkalemia (damage to or disease of the kidney): 31 people, 83.78%
  2. Renal Cell Carcinoma (a kidney cancer): 4 people, 10.81%
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Veltassa and Paxil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Veltassa and Paxil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Veltassa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Paxil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Veltassa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Paxil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on patiromer sorbitex calcium and paroxetine hydrochloride (the active ingredients of Veltassa and Paxil, respectively), and Veltassa and Paxil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.